mutLBSgeneDB |
Gene summary for TTN |
Gene summary |
Basic gene Info. | Gene symbol | TTN |
Gene name | titin | |
Synonyms | CMD1G|CMH9|CMPD4|EOMFC|HMERF|LGMD2J|MYLK5|TMD | |
Cytomap | UCSC genome browser: 2q31 | |
Type of gene | protein-coding | |
RefGenes | NM_001256850.1, NM_001267550.2,NM_003319.4,NM_133378.4,NM_133379.4, NM_133432.3,NM_133437.4, | |
Description | connectinrhabdomyosarcoma antigen MU-RMS-40.14 | |
Modification date | 20141222 | |
dbXrefs | MIM : 188840 | |
HGNC : HGNC | ||
Ensembl : ENSG00000155657 | ||
HPRD : 01787 | ||
Vega : OTTHUMG00000154448 | ||
Protein | UniProt: Q8WZ42 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_TTN | |
BioGPS: 7273 | ||
Pathway | NCI Pathway Interaction Database: TTN | |
KEGG: TTN | ||
REACTOME: TTN | ||
Pathway Commons: TTN | ||
Context | iHOP: TTN | |
ligand binding site mutation search in PubMed: TTN | ||
UCL Cancer Institute: TTN | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0051592 | response to calcium ion | 7607248 |
Top |
Ligand binding site mutations for TTN |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | V2954 | T2952I | COAD | 2 | T2945 | D2947N | COAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for TTN |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | T2945 | D2947N | -1.0899177 | V2954 | T2952I | -0.29957278 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for TTN from PDB |
PDB ID | PDB title | PDB structure | 1BPV | TITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE, NMR, 50 STRUCTURES |
Top |
Differential gene expression and gene-gene network for TTN |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for TTN |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0007193 | Cardiomyopathy, Dilated | 28 | AlteredExpression, Biomarker, GeneticVariation |
umls:C0026848 | Muscular Diseases | 10 | Biomarker, GeneticVariation |
umls:C1863599 | Hereditary Myopathy with Early Respiratory Failure | 9 | Biomarker, GeneticVariation |
umls:C1838244 | TIBIAL MUSCULAR DYSTROPHY, TARDIVE | 7 | Biomarker, GeneticVariation |
umls:C0751336 | Distal Myopathies | 5 | Biomarker, GeneticVariation |
umls:C0340427 | Familial dilated cardiomyopathy | 4 | Biomarker |
umls:C1861065 | Cardiomyopathy, Familial Hypertrophic, 9 | 2 | Biomarker, GeneticVariation |
umls:C2673677 | Myopathy, Early-Onset, with Fatal Cardiomyopathy | 1 | Biomarker, GeneticVariation |
umls:C0151786 | Muscle Weakness | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for TTN |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of TTN go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of TTN |
Multiple alignments for Q8WZ42 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |